10-54369194-G-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001384140.1(PCDH15):āc.400C>Gā(p.Arg134Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R134Q) has been classified as Pathogenic.
Frequency
Consequence
NM_001384140.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH15 | NM_033056.4 | c.400C>G | p.Arg134Gly | missense_variant | 5/33 | ENST00000320301.11 | NP_149045.3 | |
PCDH15 | NM_001384140.1 | c.400C>G | p.Arg134Gly | missense_variant | 5/38 | ENST00000644397.2 | NP_001371069.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH15 | ENST00000320301.11 | c.400C>G | p.Arg134Gly | missense_variant | 5/33 | 1 | NM_033056.4 | ENSP00000322604.6 | ||
PCDH15 | ENST00000644397.2 | c.400C>G | p.Arg134Gly | missense_variant | 5/38 | NM_001384140.1 | ENSP00000495195.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460888Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726750
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 23 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 15, 2003 | - - |
Likely pathogenic, flagged submission | clinical testing | Baylor Genetics | Mar 11, 2023 | - - |
Usher syndrome type 1F Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 19, 2023 | Variant summary: PCDH15 c.400C>G (p.Arg134Gly) results in a non-conservative amino acid change located in the Cadherin-like (IPR002126) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250744 control chromosomes. c.400C>G has been reported in the literature in multiple individuals affected with nonsyndromic hearing loss DFNB23 or Usher Syndrome Type 1F (examples: Ahmed_2008, Kletke_2015). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 18719945, 27743452). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 15, 2013 | The Arg134Gly variant in PCDH15 has been previously identified in 2 unrelated Pa kistani individuals with nonsyndromic hearing loss, both of whom were homozygous , and was absent in 500 ethnically matched chromosomes (Ahmed 2003, Ahmed 2008). In addition, the variant segregated in 4 affected family members, and all affec ted individuals were reported to have hearing loss and normal electroretinograms (Ahmed 2003, Ahmed 2008). Computational analyses (biochemical amino acid proper ties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong suppor t for or against an impact to the protein. In summary, this variant is likely to be pathogenic, though additional familial or functional studies are required to fully establish its clinical significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at